
浏览全部资源
扫码关注微信
1.武汉市第一医院药学部,武汉 430022
2.武汉市第一医院心血管内科,武汉 430022
3.湖北科技学院药学院,湖北 咸宁 437100
主管药师,硕士。研究方向:临床药学。电话:027-85332011。E-mail:xiaochunye@126.com
副主任药师,博士。研究方向:临床药学。电话:027-85332276。E-mail:53685340@qq.com
收稿日期:2023-10-11,
修回日期:2024-02-28,
录用日期:2024-03-04,
纸质出版日期:2024-04-15
移动端阅览
叶小春,张妍,祝炜,等.叙事药学在心血管药学门诊中的应用[J].中国药房,2024,35(07):872-876.
YE Xiaochun,ZHANG Yan,ZHU Wei,et al.Application of narrative pharmacy in cardiovascular pharmacy clinic[J].ZHONGGUO YAOFANG,2024,35(07):872-876.
叶小春,张妍,祝炜,等.叙事药学在心血管药学门诊中的应用[J].中国药房,2024,35(07):872-876. DOI: 10.6039/j.issn.1001-0408.2024.07.18.
YE Xiaochun,ZHANG Yan,ZHU Wei,et al.Application of narrative pharmacy in cardiovascular pharmacy clinic[J].ZHONGGUO YAOFANG,2024,35(07):872-876. DOI: 10.6039/j.issn.1001-0408.2024.07.18.
目的
2
探讨临床药师通过叙事药学管理对心血管疾病合并负面情绪患者的用药依从性、负面情绪及生活质量的影响。
方法
2
选取2023年2-8月武汉市第一医院心血管药学门诊就诊的49例有用药问题伴负面情绪的患者作为研究对象,在传统药学管理基础上,于患者就诊时及治疗2周时对患者加用叙事药学的模式进行管理。记录患者药物咨询相关问题、药物种类,对患者就诊时及管理1个月随访时的不良反应、血压及血脂、依从性、抑郁和焦虑状态、生活质量、患者满意度等变化进行比较。
结果
2
采用叙事药学管理模式的49例患者涉及114个药物相关咨询问题;与就诊时比较,管理1个
月后患者服药种类显著减少[4.00(2.00,6.00)种 vs
.
3.00(1.50,5.00)种,
P
<0.05
]
,不良反应发生率显著下降(32.65% vs. 2.04%,
P
<0.001),血压及血脂达标率显著升高(30.61% vs. 95.92%,
P
<0.001),患者用药依从性显著提高[(3.94±2.44)分 vs. (6.78±2.07)分,
P
<0.01
]
,抑郁评分显著降低[3.00(2.00,4.50)分 vs
.
2.00(0.00,3.00)分,
P
<0.001
]
,焦虑评分显著降低[3.00(2.00,4.50)分 vs
.
1.00(0.00,2.00)分,
P
<0.001
]
,生活质量评分显著提高[22.00(19.00,22.00)分 vs
.
23.00(23.00,24.50)分,
P
<0.01
]
,满意度调查中患者的满意总占比稍有提高(91.84% vs
.
97.96%,
P
>0.05)。
结论
2
叙事药学应用于心血管药学门诊,能够提高患者依从性,减少药物不良反应,加强药物治疗有效性,避免药物相互作用,有效改善患者焦虑抑郁情绪,最终提高患者生活质量。
OBJECTIVE
2
To explore the effects of narrative pharmacy management on medication compliance, negative emotions, and quality of life in patients with cardiovascular disease complicated with negative emotions.
METHODS
2
A total of 49 patients with drug use problems and negative emotions attending the cardiovascular pharmacy clinic of Wuhan First Hospital from February to August 2023 were selected as the study objects, narrative pharmacy model was applied for patient management during their visits; pharmaceutical care and emotional management were performed after 2 weeks of treatment and a follow-up visit was conducted to evaluate and record the management effect one month later.
RESULTS
2
Adopting a narrative pharmacy management model, 49 patients were involved in 114 drug related consultation questions. Compared with the visit, after one month of management, the number of medication types taken by patients significantly decreased [4.00 (2.00, 6.00) vs. 3.00 (1.50, 5.00),
P
<0.05
]
, the incidence of adverse reactions significantly decreased (32.65% vs. 2.04%,
P
<0.001), the rate of blood pressure and lipi
d compliance significantly increased (30.61% vs. 95.92%,
P
<0.001), and the score of the patient’s medication compliance significantly improved [(3.94±2.44) vs. (6.78±2.07),
P
<0.01
]
. The depression score significantly decreased [3.00 (2.00, 4.50) vs. 2.00 (0.00, 3.00),
P
<0.001
]
, the anxiety score significantly reduced [3.00 (2.00, 4.50) vs. 1.00 (0.00, 2.00),
P
<0.001
]
, quality of life score was significantly improved [22.00 (19.00, 22.00) vs. 23.00 (23.00, 24.50),
P
<0.01
]
. In the satisfaction survey, there was a slight increase in the overall satisfaction proportion (91.84% vs. 97.96%,
P
>0.05).
CONCLUSIONS
2
The application of narrative pharmacy in cardiovascular pharmacy clinic can improve patient compliance, reduce adverse drug reactions, enhance the effectiveness of drug treatment, avoid drug interactions, effectively improve the anxiety and depression, and ultimately improve the quality of life.
杨学平 , 何茹 . 综合医院心血管疾病与抑郁焦虑的相关研究进展 [J ] . 中华全科医学 , 2022 , 20 ( 2 ): 302 - 306,335 .
YANG X P , HE R . Advances in the associated study of cardiovascular disease with depression and anxiety in general hospitals [J ] . Chin J Gen Pract , 2022 , 20 ( 2 ): 302 - 306,335 .
陈晓虎 , 朱贤慧 , 陈建东 , 等 . 双心疾病中西医结合诊治专家共识 [J ] . 中国全科医学 , 2017 , 20 ( 14 ): 1659 - 1662 .
CHEN X H , ZHU X H , CHEN J D , et al . Expert consensus on the diagnosis and treatment of psycho-cardiological disease with integrated traditional Chinese and Western medicine [J ] . Chin Gen Pract , 2017 , 20 ( 14 ): 1659 - 1662 .
XIA K , WANG L F , YANG X C , et al . Comparing the effects of depression,anxiety,and comorbidity on quality-of-life,adverse outcomes,and medical expenditure in Chinese patients with acute coronary syndrome [J ] . Chin Med J , 2019 , 132 ( 9 ): 1045 - 1052 .
CHOUDHRY N K , KRONISH I M , VONGPATANASIN W , et al . Medication adherence and blood pressure control:a scientific statement from the American Heart Association [J ] . Hypertension , 2022 , 79 ( 1 ): e1 - e14 .
GRENARD J L , MUNJAS B A , ADAMS J L , et al . Depression and medication adherence in the treatment of chronic diseases in the United States:a meta-analysis [J ] . J Gen Intern Med , 2011 , 26 ( 10 ): 1175 - 1182 .
丽塔·卡伦 . 叙事医学:尊重疾病的故事 [M ] . 郭莉萍,译. 北京 : 北京医科大学出版社 , 2015 : 151 - 216 .
CHARON R . Narrative medicine:respecting the story of disease [M ] . Trans,GUO L P. Beijing : Peking University Medical Press , 2015 : 151 - 216 .
杨晓霖 . 中国叙事医学与医者职业素养 [M ] . 广州 : 广东高等教育出版社 , 2023 : 102 - 202 .
YANG X L . Chinese narrative medicine and medical professional literacy [M ] . Guangzhou : Guangdong Higher Education Press , 2023 : 102 - 202 .
CAPPUCCIO A , SANDUZZI ZAMPARELLI A , VERGA M , et al . Narrative medicine educational project to improve the care of patients with chronic obstructive pulmonary disease [J ] . ERJ Open Res , 2018 , 4 ( 2 ): 00155 - 02017 .
马丁·佩恩 . 叙事疗法 [M ] . 曾立芳,译. 北京 : 中国轻工业出版社 , 2022 : 145 - 160 .
PAYNE M . Narrative therapy [M ] . Trans,ZENG L F. Beijing : China Light Industry Press , 2022 : 145 - 160 .
杨晓霖 . 中国叙事医学体系构建共识 [J ] . 中国医学伦理学 , 2023 , 36 ( 11 ): 1177 - 1179 .
YANG X L . Consensus on the construction of narrative medicine system in China [J ] . Chinese Medical Ethics , 2023 , 36 ( 11 ): 1177 - 1179 .
鲍丽杰 , 胡振宏 , 肖建伟 , 等 . Morisky问卷测量重性抑郁障碍患者服药依从性的信效度分析 [J ] . 临床精神医学杂志 , 2014 , 24 ( 6 ): 380 - 382 .
BAO L J , HU Z H , XIAO J W , et al . Validity and reliabi- lity of the Morisky questionnaire in assessing medication compliance in patients with major depressive disorder [J ] . J Clin Psychiat , 2014 , 24 ( 6 ): 380 - 382 .
JHA M K , QAMAR A , VADUGANATHAN M , et al . Screening and management of depression in patients with cardiovascular disease:JACC state-of-the-art review [J ] . J Am Coll Cardiol , 2019 , 73 ( 14 ): 1827 - 1845 .
周善洁 . PHQ-9和GAD-7对心血管疾病住院患者焦虑抑郁状态的筛查及可靠性分析 [D ] . 兰州 : 兰州大学 , 2021 .
ZHOU S J . Screening and reliability analysis of PHQ-9 and GAD-7 for anxiety and depression in hospitalized patients with cardiovascular diseases [D ] . Lanzhou : Lanzhou University , 2021 .
崔虹旭 , 董波 . 欧洲五维健康量表在评价心血管疾病病人生活质量中的应用现状 [J ] . 中西医结合心脑血管病杂志 , 2018 , 16 ( 1 ): 57 - 59 .
CUI H X , DONG B . Application status of European five-dimensional health scale in evaluating the quality of life of patients with cardiovascular diseases [J ] . Chin J Integr Med Cardio-cerebrovascular Dis , 2018 , 16 ( 1 ): 57 - 59 .
葛卫红 . 中国临床药师成长实录 [M ] . 北京 : 人民卫生出版社 , 2018 : 2 - 67 .
GE W H . The growth record of Chinese clinical pharmacists [M ] . Beijing : People’s Medical Publishing House , 2018 : 2 - 67 .
李友佳 , 张津铭 , 张抗怀 . 试论叙事医学在药学服务中的应用 [J ] . 中国医院药学杂志 , 2020 , 40 ( 20 ): 2175 - 2178 .
LI Y J , ZHANG J M , ZHANG K H . Application of narrative medicine in pharmaceutical care [J ] . Chin J Hosp Pharm , 2020 , 40 ( 20 ): 2175 - 2178 .
CHERCHI S , SANNA S , LOGIAS F , et al . Narrative medicine:does pharmacist-patient communication improve medication adherence? [J ] . Giornale di Clinica Nefrologica e Dialisi , 2017 , 29 ( 2 ): 130 - 138 .
LEHNBOM E C , BERBAKOV M E , HOFFINS E L , et al . Elevating safe use of over-the-counter medications in older adults:a narrative review of pharmacy involved interventions and recommendations for improvement [J ] . Drugs Aging , 2023 , 40 ( 7 ): 621 - 632 .
0
浏览量
26
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
公网安备50010302001817